The website may be down at times on Saturday, December 14, and Sunday, December 15, for maintenance. 

brand logo

Am Fam Physician. 2013;88(5):334-337

Clinical Question

Does vitamin D supplementation reduce knee pain in adults with osteoarthritis?

Bottom Line

Vitamin D supplementation at a dose targeted to reach a 25-hydroxyvitamin D plasma level greater than 36 ng per mL for two years did not reduce symptomatic knee pain in adults with osteoarthritis. (Level of Evidence = 1b)

Synopsis

Another trial of supplemental vitamin D not able to show any clinical benefit—when will this medical fad run its course? These investigators identified adults 45 years or older who met standardized international criteria for knee osteoarthritis based on clinical and radiology findings. Patients randomly received (concealed allocation assignment) 2,000 IU oral cholecalciferol or matched placebo daily, with optional subsequent increments of 2,000 IU at four, eight, and 12 months, targeted to reach a 25-hydroxyvitamin D plasma level between 36 and 100 ng per mL (89.9 and 249.6 nmol per L). No supplemental calcium was given, but all patients received advice on optimal dietary calcium intake. Individuals assessing outcomes using standard pain rating scales and magnetic resonance imaging remained masked to treatment group assignment. Complete follow-up occurred for 85% of participants at 24 months.

Using intention-to-treat analysis, significantly more patients assigned to the active supplement group achieved the target plasma level of 25-hydroxyvitamin D compared with the placebo group (61.3% vs. 8.3%, respectively). However, there was no significant difference in reduction of knee pain between the two treatment groups. There were also no significant between-group differences based on magnetic resonance imaging studies in cartilage thickness or bone marrow lesion size. At 16 months, significantly more patients in the supplemental group reported increased use of nonsteroidal anti-inflammatory drugs than in the placebo group (40% vs. 22%; number needed to treat = 5.6). The study was 80% powered to detect a predetermined clinically significant difference in pain reduction between the two treatment groups.

Reference

McAlindonTLaValleyMSchneiderEet alEffect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA.2013; 309( 2): 155– 162.

Study design: Randomized controlled trial (double-blinded)

Funding source: Government

Allocation: Concealed

Setting: Outpatient (any)

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see https://www.essentialevidenceplus.com/Home/Loe?show=Sort.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

Continue Reading


More in AFP

More in PubMed

Copyright © 2013 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.